THE SWISS ORIGINAL FORMULA !

HOW DOES MF3 WORKS ?

MFIII of Switzerland hi-tech Softgels are fully researched, developed in Switzerland and Germany. The method employed in unique softgels capsules produces cells which remain biologically active [a proven technique for gently conserving biological substances], without damaging the effectiveness of the valuable big bio-active matter. The exact dosage of the cell preparations can be accurately measured and sterility controlled. Cell Therapy is a well known process in the world that has been proven safe and effective in slowing down the aging process and dramatically regaining your health, vitality and physical power. MFIII of Switzerland softgels are deemed the most perfected anti aging and cell activating oral supplement from more than 20 years of research and development. MFIII of Switzerland softgels bypass the stomach and dissolve in the small intestine whereby the active ingredients are fully absorbed by the body. The advantage of dissolution in the small intestine instead of in the stomach is that it avoids the destruction of active peptides and their functions by gastric acid thereby ensuring the bioavailability of the cell elements consumed. It is currently the most advanced bio-technological product with a very high metabolic activity. It's active ingredients are small molecular peptides which are absorbed by the body without losing their effects to induce regenerative functions. The marine cell extracts of MFIII of Switzerland extracts are from cell culture. They are very pure raw materials without any foreign contents and are 99% water soluble.

MFIII of Switzerland - THE SWISS IP SECRET IN CELL EXTRACTION

Laboratoires Dom AVMM Suisse, the Swiss Formulators & Developers of MFIII of Switzerland holds the One and Only Swiss licensed method of extraction of cell extraction. The Swiss believe, in order to maintain the bioactiveness of the active substance of cell extracts, it only be done with their Swiss unique closely guarded secret of cold enzymatic acid process during extraction without the destructuring effects of heating of 125° to 180°C as used in common sterilization process. Hence, no cell extracts are the same because the methods of extraction process are very different. Current cell extracts supplement in the markets are via conventional methods being:

(1) GROUNDING which leave impurities, heavy metals accumulated and unfiltered;

(2) LYOPHILIZATION where the cellular wall structure of the cells are unavoidably damaged during the lyophilization process, rendering a high lost of marine cell extracts high efficacy and effectiveness;

(3) STERILIZATION PROCESS where heating of 125° to 180°C virtually kills off all natural bioactiveness of any good marine cell extracts. MFIII Swiss cell extracts supplement with its unique extraction method is more bio-active and readily available to the users upon ingestion with its fully soluble spray dried material in controlled air environment throughout its unique proprietory Enzymatic Digestion process. There are lot of differences between a Rolls Royce and a Mini...

MFIII of Switzerland only utilises 1st Grade French Government Certified Cell Extracts and they are processed in contracted processing plant in France. In comparision with any other cell extracts products, MFIII of Switzerland softgels will not supply artificial hormones to our body which would affect our own hormones production. Dependency on Hormones Therapy may be effective during treatment, however will loose its effects when discontinued. This can be dangerous as it affects the natural balance of the endocrine system. With MFIII of Switzerland, the risk of allergy is highly minimized as the chance of attacking a foreign body is negligible. The Active substances in MFIII of Switzerland are extracted with hi-tech biotechnological processes. These extract so called homologous elements entered our body to contribute enormously to revitality through activation and regeneration of our damaged and aging cells. The ratio of active ingredients in MFIII of Switzerland is set after prolonged researches and trials in various scientific fields towards achievement of the best concentration of the active ingredients. Both the inner ingredients and outside lac of MFIII of Switzerland capsules are stablised. MFIII of Switzerland products are all extracted from small peptide fractions with the big molecular fat, protein and hormones removed. They are further cultivated by Cell Culture with the end results of the active parts separated and purified. They are thus very pure and does not contain any other unnecessary ingredients.

Anti Aging is only a general term which represents a whole process. With age advancement, the functions of our organs degenerates. Chronic diseases set in. When the body feels uncomfortable, symptoms such as lethargy, fatique, stress, insomia, weak concentration, weak memory, depression, irritability, nervousness, dizziness, headache and etc. With MFIII of Switzerland, all these can be greatly reduced. This also applies to menopausal symptoms such as hot flashes, night sweats, mood swings, anxiety, depression , dehydration of skins which can also be greatly alleviated. No side effects will occur for long term maintenance since the biomolecules are metabolized, degenerated and excreted via the same pathways as endogenous products.

Clinical Studies

Clinical Test 1 - BIO-HC Laboratories, Clinical Report No. TAO 01.1099, Pessac, France 2001

Lethal Doses (LD50) Toxicity Tests

Bio HC is one of Europe largest and most sophiscated Clinical Test research centre in Pessac, France under GLP (Good Laboratories Practice) and GCP (Good Clinical Practise) conditions, Bio HC in Vitro Department comprises of a group of dynamic and experienced experts. The professionals include physicians, pharmacists, dermatologists, allergologists, biochemists and bacteriologists. In order to ensure MFIII of Switzerland is totally harmless and have scientific objectivity, Bio HC in Vitro Department conducted and validated toxicological and pharmacological studies on MFIII of Switzerland. The test report was further attestated and audited by PHYCHER Bio development in France. Then MFIII of Switzerland was also further analysed by 3 other Swiss Research bodies.

Clinical Test 2 - Pharmaceutical Research, Company Inc (PRC) USA, Exton, USA 2002

Safety Profile Assessment

Pharmaceutical Research Company, Incorporated (PRC) situated in Exton, Philadelphia USA, are International Pharmaceutical Consultants to many Multi National Companies on Biotechnology, Pharmaceuticals, FDA Regulations, Analytical and Research.

Various samples of different batches of production of MFIII of Switzerland PE Softgels were further despatched across the continent to another independent New Zealand biotech laboratory, namely Canterbury Health Laboratories. Here, under the The Steriod and Immunology Unit headed by Professor John Lewis, PhD Steriod BioChemist, the samples were thoroughly tested on basis of dry weight and volume. Results were then redirected back to the USA for report on safety assessment under the professional guidance of American Professor Dr. Pardeep Gupta, Associate Professor, of Pharmacy at University of the Sciences, Philadelphia, USA.

With broard references of over 500 databases on chemical, pharmaceuticals, medicine and biotechnology from USA, Europe, Japan and NIH(National Institute of Health) and professional expertise, PRC certified and authenticated that Marine Cell Extracts (MFIII of Switzerland PE Softgels) is SAFE for human consumption on January 28, 2003.

Clinical Test 3 - Sun Yat-Sun, University Hospital, Guang Chou, China 2005

Independent Clinical Research & Testing

was carried out by Sun-Yat-Sun University Hospital, one of 2 China's renowned universities for Clinical trials. The findings was published in Chinese Journal and the Dermatology magazine of one Anti-aging Association.

Clinical Test 4 - State Food & Drug, Administration, China, Beijing, China 2005/2006

China SFDA Safety, Toxicity & Clinical Testing Approval

One of the very pre-requisite for oral supplement approvals in China was their very stringent independent SFDA government lab testings for safety, toxicity and efficacy. MFIII went through all these vigourous testing, trials, one by one. MFIII was clinically tested by Beijing Ke Siang Ba Ya Medical Research Technology Company and approved by China SFDA. In early 2006, the approval SFDA report no: 200606008 on all in testings was out successfully.

Clinical Test 5 - Lab. Intercosmetica - Zepter Group, Switzerland 2005/2006

Swiss Independent Randomised Double-Blind Placebo* Controlled Study

was headed by Professor Dr. Alain Begiun, commitee of Swiss Society of Cosmetic Chemists Swiss (SCC) and a team of Swiss professional clinicians. Clinical Report No. CTE 23A. The Proven Clinical Study was published and presented in Medical Journals and Medical Dermatology Conference of Anti-aging in Paris Europe in Oct. 2006.

CLINICALY PROVEN EVIDENCED BASED SKIN REJUVENATION EFFECTS

Within 2 months the older group shows a skin rejuvenation level of about 20 years, based on the epidemis+dermis density.

Demography

* Venue of study: Neuchatel Switzerland
* Time: September, 2005 to January 2006
* 2 groups of volunteers: Test group, Placebo group
* Healthy women, Caucasian skin type, Various races
* Skin phototype II (Fitzpatrick)
* Ages: Group ranging from 20-60 years, mean 41
* Volunteers nor research conducting personnel are aware which is the real PE Softgels nor its name or a Placebo as softgels looks totally alike.

Study on human volunteers (in vivo)

* Double-blind placebo-controlled clinical study
* 58 women aged 20-60
* No study-related side-effects reported
* 11 skin bioengineering parameters studied

Study on human volunteers (in vivo) (2)

* Noticeable effects already after four weeks
* Significant reduction of microscars after 3 months
* Improved skin smoothness
* Improved skin firmness (=dermis density)
* Reduced fine lines and wrinkles

Clinically Proven evidence of a skin smoothing effect

Computerized skin profilometry
(on skin microrelief, average roughness, forearm etc)

CONCLUSION ON RESULTS
Selected example of skin surface smoothing (vol. #12, age 46):